Macrogol Junior Von 6 Monaten Bis 8 Jahren Adgc (Macrogol 4000)

Macrogol Junior is an osmotic laxative used in pediatric gastrointestinal care. It is indicated for:

• Functional constipation: softens stool and promotes regular bowel movements.
• Encopresis: assists in establishing predictable evacuation patterns.
• Bowel preparation for diagnostic procedures: provides gentle cleansing of the colon before examinations.

• Macrogol 4000 works by retaining water within the intestinal lumen through hydrogen bonding, creating an osmotic gradient that increases stool water content. The resulting softer, bulkier stool stimulates peristalsis, facilitating easier passage without being absorbed systemically.

Macrogol Junior is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Abdominal bloating: mild distension of the abdomen.
• Flatulence: increased intestinal gas.
• Nausea: feeling of queasiness.
• Diarrhea: loose stools.
• Abdominal cramps: intermittent pain.
• Taste disturbance: temporary alteration of taste perception.

Serious or Rare Side Effects

• Severe dehydration: excessive fluid loss requiring medical attention.
• Electrolyte imbalance: abnormal levels of sodium, potassium, or other ions.
• Allergic reaction: rash, itching, swelling, or difficulty breathing.
• Severe abdominal pain: persistent or worsening pain.
• Rectal bleeding: presence of blood in stool.

When prescribing Macrogol Junior, consider the following safety measures:

• Assess hydration status: ensure the child is adequately hydrated before initiating therapy.
• Monitor electrolytes: check serum electrolytes in prolonged use or high doses.
• Use under medical supervision: dosage adjustments should be guided by a healthcare professional.
• Avoid in intestinal obstruction: contraindicated if a mechanical blockage is suspected.
• Adjust dose in renal impairment: reduced renal function may require careful dosing.
• Store at ambient temperature: keep in the original pack, protect from moisture.

Macrogol Junior can affect the absorption of concomitant oral medications.

Major Interactions (Avoid)

• Digoxin: reduced absorption may lead to therapeutic failure.
• Lithium: decreased bioavailability can alter serum levels.
• Certain antibiotics (e.g., tetracyclines, quinolones): impaired absorption may reduce efficacy.

Moderate Interactions (Monitor Closely)

• Antacids: may bind and reduce effectiveness of the laxative.
• Other laxatives: concurrent use can increase risk of electrolyte disturbances.
• Oral contraceptives: possible reduction in hormone absorption, monitor for breakthrough bleeding.